Korean J Urol.  2006 Apr;47(4):392-396. 10.4111/kju.2006.47.4.392.

Early Experience on the Effects of Sildenafil Citrate for Treating Erectile Dysfunction after Radical Retropubic Prostatectomy

• Kim YS
• Lee JS
• Chung BH

• KMID: 1997149
• DOI: http://doi.org/10.4111/kju.2006.47.4.392

Abstract

PURPOSE
We assess the efficacy of using sildenafil for treating erectile dysfunction (ED) in Korean men after they had undergone radical retropubic prostatectomy for localized prostate cancer.
MATERIALS AND METHODS
Between January 2002 and November 2004, 61 patients underwent RRP and post-operative sildenafil treatment for ED, and 50 patients were finally enrolled in this study. The subjects were divided into three groups according to the nerve sparing status (non-nerve sparing, unilateral nerve sparing and bilateral nerve sparing). Medication was initiated at 50mg, and if this was ineffective, then we added 50mg to the initial dosage. The patients were asked to fill out the self-administrated International Index of Erectile Function-5 (IIEF-5) for determining their response to sildenafil.
RESULTS
Of the 14 patients who underwent bilateral nerve sparing (NS) procedures, 4 (28%) had improved ability for intercourse. Of the 8 patients who underwent unilateral NS procedures, 2 (25%) had improved ability for intercourse. 1 of 28 patients who underwent non-NS procedures had a positive response. PDE5Is significantly improved the IIEF-5 (2.44+/-1.89 vs 8.81+/-8.24, respectively, p<0.001). Two factors, i.e., age and preoperative sexual activity, correlated with the return of sexual function. No patient discontinued the drug because of side effects.
CONCLUSIONS
For Korean men who have undergone bilateral and unilateral NS procedures, Sildenafil is effective for treating erectile dysfunction, and it may aid the recovery of erectile function after radical retropubic prostatectomy. However, non-NS procedure patients had less of a response to sildenafil. This study suggested that sildenafil is well tolerated and could be initially used for treating Korean men with erectile dysfunction after radical retropubic prostatectomy.

Keyword

Prostatectomy; Erectile dysfunction; Sildenafil; Questionnaires

MeSH Terms

Citric Acid*
Erectile Dysfunction*
Humans
Male
Prostatectomy*
Prostatic Neoplasms
Questionnaires
Sexual Behavior
Citric Acid

Figure

• 

  Fig. 1 Changes of the International Index of Erectile Function (IIEF)-5 questionnaires at baseline and after sildenafil treatment in 50 patients (*: p<0.001).

• 

  Fig. 2 Effects of sildenafil citrate on sexual function after radical prostatectomy (UNS vs NNS, p<0.01; BNS vs NNS, p<0.01; UNS vs BNS, p>0.05). NNS: non-nerve sparing, UNS: unilateral nerve sparing, BNS: bilateral nerve sparing.

Reference

1. Bacon CG, Giovannucci E, Testa M, Glass TA, Kawachi I. The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Cancer. 2002. 94:862–871.

2. Arai Y, Okubo K, Aoki Y, Maekawa S, Okada T, Maeda H, et al. Patient-reported quality of life after radical prostatectomy for prostate cancer. Int J Urol. 1999. 6:78–86.

3. Walsh PC. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. J Urol. 2000. 163:370.

4. Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J Urol. 2000. 164:1929–1934.

5. Kao TC, Cruess DF, Garner D, Foley J, Seay T, Friedrichs P, et al. Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy. J Urol. 2000. 163:858–864.

6. Geary ES, Dendinger TE, Freiha FS, Stamey TA. Nerve sparing radical prostatectomy: a different view. J Urol. 1995. 154:145–149.

7. Gralnek D, Wessells H, Cui H, Dalkin BL. Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy. J Urol. 2000. 163:1166–1169.

8. Walsh PC, Marschke P, Ricker D, Burnett AL. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology. 2000. 55:58–61.

9. Gontero P, Kirby R. Early rehabilitation of erectile function after nerve-sparing radical prostatectomy: What is the evidence? BJU Int. 2004. 93:916–918.

10. Moreland RB, Goldstein I, Traish A. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells. Life Sci. 1998. 62:PL309–PL318.

11. Sadovsky R, Miller T, Moskowitz M, Hackett G. Three-year update of sildenafil citrate (Viagra) efficacy and safety. Int J Clin Pract. 2001. 55:115–128.

12. Steers WD. Viagra--after one year. Urology. 1999. 54:12–17.

13. Moreland RB. Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res. 1998. 10:113–120.

14. Yamanaka M, Shirai M, Shiina H, Shirai M, Tanaka Y, Fujime M, et al. Loss of anti-apoptotic genes in aging rat crura. J Urol. 2002. 168:2296–2300.

15. Yao KS, Clayton M, O'Dwyer PJ. Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. J Natl Cancer Inst. 1995. 87:117–122.

16. Klein LT, Miller MI, Buttyan R, Raffo AJ, Burchard M, Devris G, et al. Apoptosis in the rat penis after penile denervation. J Urol. 1997. 158:626–630.

17. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997. 49:822–830.

18. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999. 11:319–326.

19. Ahn TY, Lee DS, Kang WC, Hong JH, Kin YS. Validation of an abridged Korean version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Korean J Urol. 2001. 42:535–540.

20. Lowentritt BH, Scardino PT, Miles BJ, Orejuela FJ, Schatte EC, Slawin KM, et al. Sildenafil citrate after radical retropubic prostatectomy. J Urol. 1999. 162:1614–1617.

21. Quinlan DM, Epstein JI, Carter BS, Walsh PC. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol. 1991. 145:998–1002.

22. Walsh PC, Marschke P, Ricker D, Burnett AL. Use of intraoperative video documentation to improve sexual function after radical retropubic prostatectomy. Urology. 2000. 55:62–67.

23. Zagaja GP, Mhoon DA, Aikens JE, Brendler CB. Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology. 2000. 56:631–634.

24. Zippe CD, Jhaveri FM, Klein EA, Kedia S, Pasqualotto FF, Kedia A, et al. Role of Viagra after radical prostatectomy. Urology. 2000. 55:241–245.

25. Ogura K, Ichioka K, Terada N, Yoshimura K, Terai A, Arai Y. Role of sildenafil citrate in treatment of erectile dysfunction after radical retropubic prostatectomy. Int J Urol. 2004. 11:159–163.

26. Kurokawa K, Suzuki T, Suzuki K, Ito K, Shimizu N, Fukabori Y, et al. A simple and reliable monitoring system to confirm the preservation of the cavernous nerves. Int J Urol. 2001. 8:231–236.

27. Klotz L, Herschorn S. Early experience with intraoperative cavernous nerve stimulation with penile tumescence monitoring to improve nerve sparing during radical prostatectomy. Urology. 1998. 52:537–542.

28. Zippe CD, Kedia AW, Kedia K, Nelson DR, Agarwal A. Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra). Urology. 1998. 52:963–966.

29. Raina R, Lakin MM, Agarwal A, Mascha E, Montague DK, Klein E, et al. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy. Urology. 2004. 63:960–966.

30. Feng MI, Huang S, Kaptein J, Kaswick J, Aboseif S. Effect of sildenafil citrate on post-radical prostatectomy erectile dysfunction. J Urol. 2000. 164:1935–1938.